Which has the lower trailing P/E, MEDP or UI?

MEDP has the lower trailing P/E: MEDP trades at 34.53 and UI at 34.68. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, MEDP or UI?

Over the past five years, MEDP grew revenue faster — MEDP at a 22.03% CAGR versus UI at 12.27%.

Does MEDP or UI pay a bigger dividend?

UI pays a dividend (0.59% yield), while MEDP has no payments in the available dividend history.

Is MEDP or UI more profitable?

UI runs the higher net margin — MEDP at 17.67% versus UI at 30.43%.

How have MEDP and UI total returns compared?

Over the past 5 years, MEDP delivered 28.06% and UI delivered 29.42% annualized total return. Past performance doesn't predict future results.

Medpace Holdings, Inc. (MEDP) vs Ubiquiti Inc. (UI)

A side-by-side comparison of Medpace Holdings, Inc. and Ubiquiti Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.

Different business models: MEDP is classified in Healthcare; UI is classified in Technology. Margin, capital intensity, and valuation differences should be interpreted in that sector context.

MEDP

Medpace Holdings, Inc.

$15.94B

$570.97HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT

Ubiquiti Inc.

$32.36B

$534.72TechnologyDelayed quote: Jul 28, 2026, 4:00 PM EDT

Total return — MEDP vs UI

growth of $100 · dividends reinvested · last 10y

MEDP +2020.8%UI +1061.0%MEDP compounded faster

MEDP UI

MEDP vs UI: by the numbers

•UI is the larger company ($32.36B vs $15.94B market cap).
•MEDP trades at the lower trailing earnings multiple (34.53 vs 34.68 P/E), one valuation lens rather than an overall verdict.
•UI converts more revenue to profit (30.43% vs 17.67% net margin).
•MEDP grew revenue faster over the past five years (22.03% vs 12.27% CAGR).
•UI pays a dividend (0.59% yield), while MEDP has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	MEDP	UI
P/E ratio	34.53	34.68
Forward P/E	33.60	35.38
P/S ratio	6.09	10.56
P/B ratio	39.07	27.19
PEG ratio	1.82	0.34
EV / EBITDA	27.73	28.78
FCF yield	4.51%	2.29%

Profitability

Metric	MEDP	UI
Gross margin	28.76%	46.02%
Operating margin	20.97%	35.75%
Net margin	17.67%	30.43%
ROE	113.29%	78.37%
ROIC	67.94%	72.62%

Dividends

Metric	MEDP	UI
Dividend yield	N/A	0.59%
Payout ratio	N/A	27.19%

Growth (annualized)

Metric	MEDP	UI
Revenue CAGR (5Y)	22.03%	12.27%
EPS CAGR (5Y)	30.90%	15.17%
FCF CAGR (5Y)	24.42%	6.21%
Total return CAGR (5Y)	28.06%	13.32%

Frequently asked

Which has the lower trailing P/E, MEDP or UI?: MEDP has the lower trailing P/E: MEDP trades at 34.53 and UI at 34.68. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, MEDP or UI?: Over the past five years, MEDP grew revenue faster — MEDP at a 22.03% CAGR versus UI at 12.27%.
Does MEDP or UI pay a bigger dividend?: UI pays a dividend (0.59% yield), while MEDP has no payments in the available dividend history.
Is MEDP or UI more profitable?: UI runs the higher net margin — MEDP at 17.67% versus UI at 30.43%.
How have MEDP and UI total returns compared?: Over the past 5 years, MEDP delivered 28.06% and UI delivered 29.42% annualized total return. Past performance doesn't predict future results.

Go deeper

Full MEDP analysis Full UI analysis Interactive comparison tool

Dig into the metrics

Medpace P/E ratio Ubiquiti P/E ratio Medpace dividend yield Ubiquiti dividend yield Medpace ROE Ubiquiti ROE Medpace operating margin Ubiquiti operating margin Medpace revenue growth Ubiquiti revenue growth Medpace free cash flow Ubiquiti free cash flow

Medpace & Ubiquiti appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.